|By Marketwired .||
|January 27, 2014 06:30 AM EST||
BETHLEHEM, PA -- (Marketwired) -- 01/27/14 -- Surrounded by a United Nations assembly of leaders shaping the future of concussion research, Dr. Adam Simon, CEO of Cerora, Inc., a StartUp Health / GE Healthcare Entrepreneurship program and Ben Franklin Technology Partners of Northeastern Pennsylvania company, will present new top line results from their concussion collaboration with Lehigh University Sports Medicine utilizing the Company's "near the field" (SM) brain bio-sensor technology.
The result of extensive 22-month collaboration with Lehigh University Sports Medicine and its director, Mr. Jack Foley, the study addresses the detection and management of concussion in college varsity athletes. The data consists of multiple scans from over 20 concussed athletes as well as 20 case-matched non-injured teammates.
"Lehigh's Jack Foley and his team have done an exceptional job collecting longitudinal data -- typically sampling as few as 6 and as many as 10 time points -- during both the symptomatic and asymptomatic phases." commented Dr. Simon. "This extremely unique data set should enable us to design objective predictive models that will aid field clinicians and healthcare professionals in both 'diagnostic' and 'return to play' decisions when they deal with suspected concussions."
Objective data -- provided rapidly, near the athletic field -- would offer a considerable advantage over current assessments which are typically based solely on subjective clinical impressions.
Cerora's proprietary MindReader multi-biosensor brainwave sensing technology is designed to enable professionals to gather truly objective data, which, along with neurophysiological performance data, self-reporting of symptoms, and additional biosensor-based measures, can lead to far more accurate determinations.
On-site Interviews: To request a one-to-one meeting with Company representatives this week in Manhattan, please e-mail Russell Miller at firstname.lastname@example.org.
Cerora is leading the way in the development and testing of software and hardware technologies required to provide critically important, objective, portable biomarker-based brain-function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania's TechVentures on Lehigh University's Mountaintop Campus in Bethlehem, Pennsylvania, the Company has assembled a team of experienced medical scientists and management professionals under the leadership of CEO Adam J. Simon, PhD, a noted physicist and globally-recognized brain biomarker expert.
About Lehigh University & Lehigh Sports Medicine
Lehigh University is a highly ranked, world-class research institution located in Bethlehem, Pennsylvania which provides an interdisciplinary educational experience for some of the best and brightest scholars. Under the direction of Jack Foley, Lehigh Sports Medicine has 7 Athletic Trainers with over 50 years combined experience who work independently and interdependently to provide prevention, care, and rehabilitation for the over 600 student-athletes participating in 25 Division-1 intercollegiate athletic teams within the Patriot League.
Over the past fifteen years, Lehigh Sports Medicine has continued to be a leader in the areas of skin infection prevention and management, concussion prevention and management, injury prevention programming, environmental policies, recruit medical screening, and student-athlete education. As a result of their excellent reputation and cutting edge approach, Jack Foley and his staff have been afforded the opportunity to participate in several ground breaking clinical research studies.
For additional information please visit www.cerora.com